Biotrend Cevre Ve Stock Shares Outstanding
| BIOEN Stock | TRY 17.85 0.15 0.85% |
Biotrend Cevre ve fundamentals help investors to digest information that contributes to Biotrend Cevre's financial success or failures. It also enables traders to predict the movement of Biotrend Stock. The fundamental analysis module provides a way to measure Biotrend Cevre's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotrend Cevre stock.
Biotrend |
Biotrend Cevre ve Company Shares Outstanding Analysis
Biotrend Cevre's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biotrend Cevre ve has 0.0 of shares currently outstending. This is 100.0% lower than that of the Utilities sector and about the same as Utilities—Renewable (which currently averages 0.0) industry. The shares outstanding for all Turkey stocks is 100.0% higher than that of the company.
Biotrend Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotrend Cevre's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotrend Cevre could also be used in its relative valuation, which is a method of valuing Biotrend Cevre by comparing valuation metrics of similar companies.Biotrend Cevre is currently under evaluation in shares outstanding category among its peers.
Biotrend Fundamentals
| Return On Equity | 0.0978 | |||
| Return On Asset | 0.0657 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.22 % | |||
| Shares Owned By Insiders | 67.23 % | |||
| Shares Owned By Institutions | 1.80 % | |||
| Price To Earning | 114.34 X | |||
| Revenue | 427.7 M | |||
| Gross Profit | 123.34 M | |||
| EBITDA | 84.88 M | |||
| Net Income | 3.79 M | |||
| Cash And Equivalents | 25.91 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 696.56 M | |||
| Debt To Equity | 2.09 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | (326.18 M) | |||
| Earnings Per Share | 0.01 X | |||
| Target Price | 13.1 | |||
| Number Of Employees | 529 | |||
| Total Asset | 1.83 B | |||
| Net Asset | 1.83 B |
About Biotrend Cevre Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotrend Cevre ve's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotrend Cevre using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotrend Cevre ve based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.